Author(s)

Vera Clérigo^*, Lígia Fernandes, Tiago Abreu, Pedro Barradas

Oncologic Pulmonology Department, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.

Pulmonary mucormycosis is an emergent and life-threatening invasive fungal infection underdiagnosed by clinicians due to unspecific clinical picture and lack of awareness. Although the acknowledgment of risk factors, clinical and radiological findings may increase early recognition, the definite diagnosis is challenging to establish and the ideal treatment has never been delineated. The authors describe a rare case of pulmonary mucormycosis that was successfully treated with dual antifungal treatment and surgery in a patient with uncontrolled diabetes. When last evaluated, he was asymptomatic with no evidence of relapse. To our knowledge this is a rare report of a successfully treated diabetic patient with pulmonary mucormycosis with L-AmB, triazole posaconazole and surgery with no evidence of recurrence. We highlight the importance of clinicians’ awareness to early diagnosis, combined antifungal treatment and adjuvant surgery as the greatest chance of cure of a rapidly progressive disease with high mortality and morbidity.

Pulmonary Mucormycosis, Diabetes, High Mortality

Clérigo, V. , Fernandes, L. , Abreu, T. and Barradas, P. (2016) A Rare Case of Pulmonary Mucormycosis Successfully Treated with Dual Antifungal Agents and Surgery in a Patient with Uncontrolled Diabetes. Open Journal of Respiratory Diseases, 6, 35-40. doi: 10.4236/ojrd.2016.62005.